|
시장보고서
상품코드
1360049
북미의 인공심폐 시장 예측(-2028년) : 지역별 분석 - 제품별, 용도별, 유형별, 연령층별, 최종 용도별North America Cardiopulmonary Oxygenator Market Forecast to 2028 -Regional Analysis - By Product, Application, Type, Age Group, and End Use |
||||||
북미의 인공심폐 시장은 2022년에 2억 6,135만 달러로 평가되고 2028년에는 3억 3,451만 달러에 달할 것으로 예측되고 있습니다. 2022-2028년의 CAGR은 4.2%로 추정됩니다.
고령화로 인한 수술 증가가 북미의 인공심폐 시장을 활성화
수술은 심혈관 질환이나 폐 질환과 같은 건강 상태를 관리하기 위해 필요합니다. 2020년 국립생물공학정보센터(NCBI)에 게재된 논문에 따르면 매년 세계에서 약 3억 1,000만 건의 대수술이 이루어지고 있으며, 그 중 5,000만-6,000만 건이 미국에서 이루어지고 있습니다. 심혈관 수술에 대한 높은 수요는 고령화 사회에서 심혈관 질환의 발생률 증가에 기인합니다. 또한 폐 이식은 심각한 폐 손상이나 COVID-19와 관련된 호흡 부전이 치유되지 않는 환자에게 유일하게 유용한 치료법이 될 수 있습니다. 이처럼 심혈관계 및 폐 이식 수술이 증가함에 따라 이 지역에서는 심폐 산소 공급 장비에 대한 수요도 증가하고 있습니다.
WHO에 따르면 60세 이상 노인의 비율은 2015년 12%에서 2050년에는 22%에 달할 것으로 추정됩니다. 심혈관 질환은 65세 이상 성인의 사망 원인 중 1위를 차지합니다. 노화는 심장과 혈관에 변화를 가져와 이러한 질병의 발병 위험을 높입니다. 따라서 노인 인구의 심혈관 질환의 유행은 인공 심폐 시장의 성장에 기여하고 있습니다.
북미 인공심폐 시장 개요
북미 인공심폐 시장은 미국, 캐나다, 멕시코로 구분됩니다. 미국은 이 지역에서 가장 큰 시장 기여를 할 것으로 예상됩니다. 북미 시장의 성장은 이 지역의 심혈관 및 호흡기 질환의 유병률 증가에 기인합니다. 이로 인해 COPD, 만성 기관지염, 울혈성 심부전 등 심폐 질환의 발병률이 증가하고 있습니다. 예를 들어 미국 폐협회에 따르면 2020년 미국에서 1,250만 명이 COPD, 만성 기관지염, 폐기종 진단을 받을 것으로 예상됩니다. 또한 이러한 질병의 유병률과 발병률 증가는 많은 환자 집단에서 외과적 시술의 수를 증가시켜 심폐 산소 공급기 시장의 성장을 가속하고 있습니다. 예를 들어 lifespan health system의 조사에 따르면 미국에서는 매년 50만 건의 개심술이 시행되고 있습니다. 또한 호흡부전 및 감염 증가로 인해 인공심폐에 대한 수요가 더욱 높아질 것으로 예상됩니다.
또한 심혈관계 질환의 유병률 증가는 세계에서 주요 사망 원인이며, 산소호흡기는 응급 상황에서 생명을 구하는 데 큰 도움이 됩니다. 세계보건기구(WHO)에 따르면 매년 1,790만 명이 CVD로 인해 목숨을 잃고 있습니다. 또한 유리한 상환 정책도 심폐 산소 장비의 성장에 충분한 기회를 제공할 것으로 예상됩니다. 따라서 심폐 질환의 유병률과 발생률 증가는 예측 기간 중 심폐 산소 장비 시장의 성장을 가속할 것으로 보입니다.
북미 인공심폐 시장 매출 및 2028년까지의 예측(금액)
북미 인공 심폐 시장 세분화
북미 인공심폐 시장은 제품, 용도, 유형, 연령대, 최종 용도, 국가별로 세분화됩니다. 제품별로는 멤브레인형 산소 공급기와 기포형 산소 공급기로 나뉘며, 2022년에는 멤브레인형 산소 흡입기가 시장 점유율을 차지할 것으로 예상됩니다.
용도별로는 심장용과 호흡기용으로 나뉘며, 2022년에는 심장용이 시장 점유율이 더 큽니다. 또한 심장은 급성 심근경색, 심근염, 이식 후 합병증, 보상성 심근증, 기타로 구분됩니다. 또한 호흡기는 호흡부전, 급성 호흡곤란 증후군, 폐색전증, 폐렴, COVID-19 등으로 세분화됩니다.
유형별로 보면 시장은 재사용 가능한 인공심폐와 일회용 인공심폐로 나뉘며, 2022년 시장 점유율은 재사용 가능한 인공심폐가 더 큽니다.
연령대별로 보면 시장은 성인, 소아, 신생아로 나뉩니다. 성인은 2022년에 가장 큰 시장 점유율을 차지했습니다.
최종 사용처에 따라 시장은 병원 및 클리닉, 외래수술센터(ASC), 기타로 구분되며, 2022년에는 병원 및 클리닉이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
국가별로는 시장은 미국, 캐나다, 멕시코로 구분됩니다. 미국이 2022년의 시장 점유율을 독점했습니다.
Getinge AB, LivaNova Plc, Medtronic Plc, Terumo Corp, Nipro Medical Corp, Microport Scientific Corp, Braile Biomedica Industry, Commerce and Representation Ltd, Chalice Medical Ltd, Fresenius Medical Care AG &Co KGaA가 이 지역 인공심폐 시장에서 사업을 운영하고 있는 주요 기업입니다.
목차
제1장 서론
제2장 북미의 인공심폐 시장 요점
제3장 조사 방법
- 조사 범위
- 2차 조사
- 1차 조사
제4장 북미의 인공심폐 시장 구도
- 개요
- PEST 분석
- 북미의 PEST 분석
전문가의 견해
제5장 북미의 인공심폐 시장 - 주요 시장 역학
- 시장 촉진요인
- 심폐 질환의 발생률 증가
- 고령화에 수반하는 외과수술의 증가
- 시장 억제요인
- 숙련 전문가의 부족
- 시장 기회
- 소아 및 신생아 환자에서 인공심폐의 사용 증가
- 향후 동향
- 폐이식술에서 휴대용 체외식막산소화의 사용
- 영향 분석
제6장 인공심폐 시장 - 북미 분석
- 북미의 인공심폐 시장 매출과 예측 분석
제7장 북미의 인공심폐 시장 - 2028년까지의 매출과 예측 - 제품별
- 인공심폐 시장의 제품별 매출 점유율(2021년·2028년)
- 막식 산소 공급기
- 버블식 산소 공급기
제8장 북미의 인공심폐 시장 - 용도별 매출과 2028년까지의 예측
- 인공심폐 시장 2021년 및 2028년 유형별 판매고 점유율(%)
- 심장용
- 호흡기
제9장 북미의 인공심폐 시장 분석과 2028년까지의 예측 - 유형별
- 인공심폐 시장 : 유형별 2021년·2028년(%)
- 재이용형 산소 공급기
- 일회용 산소 공급기
제10장 북미의 인공심폐 시장 분석과 2028년까지의 예측 : 연령층별
- 인공심폐 시장 : 연령층별 2021년·2028년(%)
- 성인
- 소아
- 신생아
제11장 북미의 인공심폐 시장 : 최종 사용별 매출과 2028년까지의 예측
- 인공심폐 시장 최종 사용별 판매고 점유율(2021년·2028년)
- 병원 및 진료소
- 외래 수술 센터
- 기타
제12장 북미의 인공심폐 시장 : 매출과 2028년까지의 예측 : 국가별 분석
- 북미
제13장 북미의 인공심폐 시장 - 업계 상황
- 인공심폐 시장의 성장 전략
- 유기적 성장 전략
- 무기적 성장 전략
제14장 기업 개요
- Getinge AB
- LivaNova Plc
- Medtronic Plc
- Terumo Corp
- Nipro Medical Corp
- MicroPort Scientific Corp
- Braile Biomedica Industry, Commerce and Representations Ltd
- Chalice Medical Ltd
- Fresenius Medical Care AG & Co KGaA
제15장 부록
KSA 23.10.19The North America Cardiopulmonary Oxygenator Market was valued at US$ 261.35 million in 2022 and is expected to reach US$ 334.51 million by 2028. It is estimated to register a CAGR of 4.2% from 2022 to 2028.
Increasing Surgical Procedures with Surging in Aging Population is Fueling North America Cardiopulmonary Oxygenator Market
Surgical procedures are necessary for managing health conditions such as cardiovascular diseases and lung disorders. In some medical cases, no alternative works without surgery. Per an article published in the National Center for Biotechnology Information (NCBI) in 2020, ~310 million major surgical operations are carried out each year worldwide, of which 50-60 million are performed in the US. The high demand for cardiovascular surgeries can be attributed to the increase in the incidence of cardiovascular diseases in the aging population. Further, lung transplantation may be the only helpful treatment option for patients experiencing serious lung damage and non-resolving COVID-19-associated respiratory failure. Thus, with the growing number of cardiovascular and lung transplant surgeries, the demand for cardiopulmonary oxygenators is also on the rise in the region.
According to the WHO, the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. Cardiovascular diseases continue to be the leading cause of death among adults over the age of 65. Aging can cause changes in the heart and blood vessels, increasing the risk of developing these diseases. Therefore, the prevalence of cardiovascular diseases among geriatric populations is contributing to the growth of the cardiopulmonary oxygenators market.
North America Cardiopulmonary Oxygenator Market Overview
The cardiopulmonary oxygenators market in North America is segmented into the US, Canada, and Mexico. The US is expected to be the largest contributor to the market in this region. The market growth in North America is ascribed to the rising prevalence of cardiovascular and respiratory disorders in the region. This has increased the incidence of cardiopulmonary disorders such as COPD, chronic bronchitis, congestive heart failure, and others. For instance, as per American Lung Association, ~12.5 million people are diagnosed with COPD, chronic bronchitis, and emphysema in the US in 2020. Moreover, rising prevalence and incidences of such disorders have increased the number of surgical procedures among large patient population which has fueled the growth of cardiopulmonary oxygenator market. For instance, as per study published by lifespan health system, ~500,00 open heart surgeries are performed in the US every year. Additionally, increase in prevalence of respiratory failure and infectious diseases are further expected to create demand for cardiopulmonary oxygenator.
Furthermore, rising prevalence of cardiovascular disorders are the leading cause of death on the global level and oxygenator can be of great assistance in lifesaving in emergency cases. As per world health organization, ~17.9 million lives are lost due to CVDs annually. Moreover, favorable reimbursement policies are also expected to create ample opportunities for the growth of cardiopulmonary oxygenator. Therefore, rising prevalence and incidence of cardiopulmonary disorders are expected to drive the growth of cardiopulmonary oxygenator market during the forecast period.
North America Cardiopulmonary Oxygenator Market Revenue and Forecast to 2028 (US$ Million)
North America Cardiopulmonary Oxygenator Market Segmentation
The North America Cardiopulmonary Oxygenator Market is segmented into product, application, type, age group, end use, and country. Based on product, the market is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held a larger market share in 2022.
Based on application, the market is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2022. Further, cardiac is segmented into acute myocardial infarction, myocarditis, post-transplant complications, decompensated cardiomyopathy, and others. Further, respiratory is segmented into respiratory failure, acute respiratory distress syndrome, pulmonary embolism, pneumonia, and COVID-19.
Based on type, the market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held a larger market share in 2022.
Based on age group, the market is segmented into adults, pediatric, and neonates. The adults segment held the largest market share in 2022.
Based on end use, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.
Based on country, the market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2022.
Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Nipro Medical Corp; Microport Scientific Corp; Braile Biomedica Industry, Commerce and Representation Ltd; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA are the leading companies operating in the Cardiopulmonary Oxygenator Market in the region.
Reasons to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Cardiopulmonary Oxygenator market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in North America Cardiopulmonary Oxygenator market, thereby allowing players across the value chain to develop effective long-term strategies
- develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the Cardiopulmonary Oxygenator market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Table Of Contents
1. Introduction
- 1.1 Scope of the Study
- 1.2 The Insight Partners Research Report Guidance
- 1.3 Market Segmentation
- 1.3.1 North America Cardiopulmonary Oxygenator Market - by Product
- 1.3.2 North America Cardiopulmonary Oxygenator Market - by Application
- 1.3.3 North America Cardiopulmonary Oxygenator Market - by Type
- 1.3.4 North America Cardiopulmonary Oxygenator Market - by Age Group
- 1.3.5 North America Cardiopulmonary Oxygenator Market - by End Use
- 1.3.6 North America Cardiopulmonary Oxygenator Market - by Country
2. North America Cardiopulmonary Oxygenator Market Key Takeaways
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. North America Cardiopulmonary Oxygenator Market - Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
Expert's Opinion
5. North America Cardiopulmonary Oxygenators Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Rise in Incidence of Cardiopulmonary Diseases
- 5.1.2 Increasing Surgical Procedures with Surging in Aging Population
- 5.2 Market Restraints
- 5.2.1 Lack of Skilled Professionals
- 5.3 Market Opportunities
- 5.3.1 Increasing Usage of Cardiopulmonary Oxygenators in Pediatric and Neonatal Patients
- 5.4 Future Trends
- 5.4.1 Use of Portable Extracorporeal Membrane Oxygenation in Lung Transplant Procedures
- 5.5 Impact Analysis
6. Cardiopulmonary Oxygenators Market - North America Analysis
- 6.1 North America Cardiopulmonary Oxygenators Market Revenue Forecast and Analysis
7. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Product
- 7.1 Overview
- 7.2 Cardiopulmonary Oxygenators Market Revenue Share, by Product 2021 & 2028 (%)
- 7.3 Membrane Oxygenator
- 7.3.1 Overview
- 7.3.2 Membrane Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 7.4 Bubble Oxygenator
- 7.4.1 Overview
- 7.4.2 Bubble Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
8. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Application
- 8.1 Overview
- 8.2 Cardiopulmonary Oxygenators Market Revenue Share, by Type 2021 & 2028 (%)
- 8.3 Cardiac
- 8.3.1 Overview
- 8.3.2 Cardiac: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.3.3 Acute myocardial infarction
- 8.3.4 Overview
- 8.3.5 Acute myocardial infarction: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.3.6 Myocarditis
- 8.3.7 Overview
- 8.3.8 Myocarditis: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.3.9 Post-transplant complication
- 8.3.10 Overview
- 8.3.11 Post-transplant complication: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.3.12 Decompensated Cardiomyopathy
- 8.3.13 Overview
- 8.3.14 Decompensated Cardiomyopathy: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.3.15 Others
- 8.3.16 Overview
- 8.3.17 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4 Respiratory
- 8.4.1 Overview
- 8.4.2 Respiratory: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4.3 Respiratory Failure
- 8.4.4 Overview
- 8.4.5 Respiratory Failure: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4.6 Acute Respiratory Distress Syndrome
- 8.4.7 Overview
- 8.4.8 Acute Respiratory Distress Syndrome: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4.9 Pulmonary Embolism
- 8.4.10 Overview
- 8.4.11 Pulmonary Embolism: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4.12 Pneumonia
- 8.4.13 Overview
- 8.4.14 Pneumonia: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 8.4.15 COVID-19
- 8.4.16 Overview
- 8.4.17 COVID-19: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
9. North America Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Type
- 9.1 Overview
- 9.2 Cardiopulmonary Oxygenators Market, by Type 2021 & 2028 (%)
- 9.3 Reusable Oxygenator
- 9.3.1 Overview
- 9.3.2 Reusable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 9.4 Disposable Oxygenator
- 9.4.1 Overview
- 9.4.2 Disposable Oxygenator: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
10. North America Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Age Group
- 10.1 Overview
- 10.2 Cardiopulmonary Oxygenators Market, by Age Group 2021 & 2028 (%)
- 10.3 Adults
- 10.3.1 Overview
- 10.3.2 Adults: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 10.4 Pediatric
- 10.4.1 Overview
- 10.4.2 Pediatric: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 10.5 Neonates
- 10.5.1 Overview
- 10.5.2 Neonates: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
11. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by End Use
- 11.1 Overview
- 11.2 Cardiopulmonary Oxygenators Market Revenue Share, by End Use 2021 & 2028 (%)
- 11.3 Hospitals and Clinics
- 11.3.1 Overview
- 11.3.2 Hospitals and Clinics: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 11.4 Ambulatory Surgical Centers
- 11.4.1 Overview
- 11.4.2 Ambulatory Surgical Centers: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
- 11.5 Others
- 11.5.1 Overview
- 11.5.2 Others: Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 (US$ Million)
12. North America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Country Analysis
- 12.1 North America: Cardiopulmonary Oxygenators Market
- 12.1.1 Overview
- 12.1.3 North America: Cardiopulmonary Oxygenators Market, by Country, 2021 & 2028 (%)
- 12.1.3.1 United States: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
- 12.1.3.1.1 Overview
- 12.1.3.1.2 United States: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
- 12.1.3.1.3 United States: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
- 12.1.3.1.4 United States: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
- 12.1.3.1.4.1 United States: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
- 12.1.3.1.4.2 United States: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
- 12.1.3.1.5 United States: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
- 12.1.3.1.6 United States: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
- 12.1.3.1.7 United States: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
- 12.1.3.2 Canada: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
- 12.1.3.2.1 Overview
- 12.1.3.2.2 Canada: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
- 12.1.3.2.3 Canada: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
- 12.1.3.2.4 Canada: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
- 12.1.3.2.4.1 Canada: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
- 12.1.3.2.4.2 Canada: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
- 12.1.3.2.5 Canada: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
- 12.1.3.2.6 Canada: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
- 12.1.3.2.7 Canada: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
- 12.1.3.3 Mexico: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
- 12.1.3.3.1 Overview
- 12.1.3.3.2 Mexico: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
- 12.1.3.3.3 Mexico: Cardiopulmonary Oxygenators Market, by Product, 2019-2028 (USD Million)
- 12.1.3.3.4 Mexico: Cardiopulmonary Oxygenators Market, by Application, 2019-2028 (USD Million)
- 12.1.3.3.4.1 Mexico: Cardiopulmonary Oxygenators Market, by Cardiac Application, 2019-2028 (USD Million)
- 12.1.3.3.4.2 Mexico: Cardiopulmonary Oxygenators Market, by Respiratory Application, 2019-2028 (USD Million)
- 12.1.3.3.5 Mexico: Cardiopulmonary Oxygenators Market, by Type, 2019-2028 (USD Million)
- 12.1.3.3.6 Mexico: Cardiopulmonary Oxygenators Market, by Age Group, 2019-2028 (USD Million)
- 12.1.3.3.7 Mexico: Cardiopulmonary Oxygenators Market, by End Use, 2019-2028 (USD Million)
- 12.1.3.1 United States: Cardiopulmonary Oxygenators Market - Revenue and forecast to 2028 (USD Million)
13. North America Cardiopulmonary Oxygenators Market-Industry Landscape
- 13.1 Overview
- 13.2 Growth Strategies in Cardiopulmonary Oxygenator Market
- 13.3 Organic Growth Strategies
- 13.3.1 Overview
- 13.4 Inorganic Growth Strategies
- 13.4.1 Overview
14. Company Profiles
- 14.1 Getinge AB
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
- 14.2 LivaNova Plc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
- 14.3 Medtronic Plc
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
- 14.4 Terumo Corp
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
- 14.5 Nipro Medical Corp
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
- 14.6 MicroPort Scientific Corp
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
- 14.7 Braile Biomedica Industry, Commerce and Representations Ltd
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.8 Chalice Medical Ltd
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
- 14.9 Fresenius Medical Care AG & Co KGaA
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
- 15.1 About The Insight Partners
- 15.2 Glossary of Terms
